Clover Health Investments Corp (CLOV)
NASDAQ:CLOV
Want to see CLOV full AI Analyst Report?
CLOV Stock Chart & Stats
$2.19
-$0.09(-2.50%)
At close: 4:00 PM EST
$2.19
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$1.58 - $5.22
Previous CloseN/A
Volume2.53M
Average Volume (3M)9.34M
Market Cap
$2.63B
Enterprise Value$2.31B
Total Cash (Recent Filing)$177.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 10, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding430,969,400
10 Day Avg. Volume10,720,894
30 Day Avg. Volume9,343,971
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit5.69
Enterprise Value/Ebitda-41.92
Forecast
1Y Price Target
$4.48Price Target Upside104.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.04
Revenue Forecast (FY)$2.91B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA cash-rich, virtually debt-free balance sheet provides durable financial flexibility to self-fund growth, absorb reserve volatility, and invest in care and technology. This lowers solvency risk for an insurer reliant on timely CMS payments and supports multi-year execution of cohort maturation strategies.
Rapid Membership Growth & Market PositionSustained, large membership expansion increases predictable capitation revenue and creates scale advantages: denser provider relationships, better care integration, and improved unit economics as cohorts mature. Scale in core markets (e.g., leading PPO position in NJ) supports durable cost management.
Clinical Tech Adoption & Cohort EconomicsBroad adoption of Clover Assistant and expanding home-care (Clover Care) indicate structural capability to manage utilization and improve outcomes. Technology-driven care management can sustainably lower medical cost ratios as cohorts age, converting scale into lasting margin improvement and potential SaaS revenue.
Bears Say
TTM Net Margin Still NegativeDespite quarter-level GAAP profit, trailing results show negative net margins, highlighting that profitability remains uneven. Persistent negative TTM margins indicate remaining execution gaps and constrain return on equity; sustained positive margins across cycles are required to validate the business model long-term.
Elevated Outpatient Utilization & Part D UncertaintyRising outpatient utilization and ongoing Part D/risk-adjustment variability are structural cost and revenue risks for a Medicare Advantage insurer. Higher outpatient trends increase medical loss ratios, while unpredictable risk scores or Part D impacts can alter CMS capitation economics, pressuring sustainable margins.
Cohort Maturation & Cash-Flow VolatilityPositive operating and free cash flow is encouraging, but volatility and reliance on cohort maturation create execution risk. If newer member cohorts or reserve development underperform, cash generation could swing, stressing investment plans and requiring continued operational discipline to lock in durable free cash flow.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments Corp’s price range in the past 12 months?
Clover Health Investments Corp lowest stock price was $1.58 and its highest was $5.22 in the past 12 months.
What is Clover Health Investments Corp’s market cap?
Clover Health Investments Corp’s market cap is $2.63B.
When is Clover Health Investments Corp’s upcoming earnings report date?
Clover Health Investments Corp’s upcoming earnings report date is Aug 10, 2026 which is in 48 days.
How were Clover Health Investments Corp’s earnings last quarter?
Clover Health Investments Corp released its earnings results on May 06, 2026. The company reported $0.073 earnings per share for the quarter, beating the consensus estimate of $0.069 by $0.004.
Is Clover Health Investments Corp overvalued?
According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued.
Does Clover Health Investments Corp pay dividends?
Clover Health Investments Corp pays a N/A dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Clover Health Investments Corp dividends here
What is Clover Health Investments Corp’s EPS estimate?
Clover Health Investments Corp’s EPS estimate is 0.04.
How many shares outstanding does Clover Health Investments Corp have?
Clover Health Investments Corp has 430,969,400 shares outstanding.
What happened to Clover Health Investments Corp’s price movement after its last earnings report?
Clover Health Investments Corp reported an EPS of $0.073 in its last earnings report, beating expectations of $0.069. Following the earnings report the stock price went up 5.224%.
Which hedge fund is a major shareholder of Clover Health Investments Corp?
Currently, no hedge funds are holding shares in CLOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.48 (104.34% Upside)
$4.48 (104.34% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $574.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 14.7%
Last 30 Days ▲ 14.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.35%
12-Months-Change
Fundamentals
Return on Equity
-17.08%
Trailing 12-Months
Asset Growth
19.53%
Trailing 12-Months
Company Description
Clover Health Investments Corp
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
CLOV Company Deck
CLOV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong set of operational and financial positives: rapid membership growth (~51% YoY), significant revenue growth (+62% YoY), improved gross profit (+47% YoY), GAAP profitability ($27M) and expanding clinical engagement (Clover Assistant reach and Clover Care enrollment up ~90%). Management acknowledged elevated outpatient utilization, Part D and prior-period reserve variability and one-time SG&A items, but described concrete actions (AI/data, dental cost controls, targeted remediation) and emphasized disciplined monitoring. Given the magnitude and breadth of the favorable metrics and the balance of challenges being described as manageable or being actively addressed, the overall tone is optimistic and confidence-driven while cautious on cohort maturation risks.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$4.48
▲(104.34% Upside)
Technical Analysis
Ownership Overview
7.03% Insiders
7.91% Mutual Funds
0.78% Other Institutional Investors
73.70% Public Companies and
Individual Investors